Extensive evidence indicates that IL-23 is involved in regulating mucosal inflammatory responses in the gut and plays crucial roles in the pathophysiology of several diseases, including inflammatory bowel disease, ulcerative colitis, and Crohn’s disease (11–14). Here, IL37 is linked to Crohn disease.